INS and type 2 diabetes mellitus: Moreover, T2DM mice treated with 3-MA exhibited worsened cognitive function (Fig. 1C–F), with no significant difference in IPGTT result, glucose level, and plasma insulin (Additional file 1: Fig. S1B–D).